MOLLIE WILT: Open Payments
NPI 1619531951 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,528 in 50 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,164 · 2025 $1,528
Food & beverage: $1,523Education: $5
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $451 |
| UCB, Inc. | 14 | $359 |
| Regeneron Healthcare Solutions, Inc. | 9 | $153 |
| Galderma Laboratories, L.P. | 1 | $123 |
| Janssen Biotech, Inc. | 1 | $105 |
| ABBVIE INC. | 5 | $104 |
| LEO Pharma Inc. | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Organon LLC | 2 | $53 |
| Botanix SB Inc | 1 | $17 |
Products named: Bimzelx, Otezla, DUPIXENT, NEMLUVIO, TREMFYA, SKYRIZI, ADBRY, COSENTYX.
Industry payments across FL — which companies pay providers there.
